ArticleObesity surgery2026
Association Between Edmonton Obesity Staging System Severity and 90-Day Postoperative Complications After Primary Metabolic and Bariatric Surgery: A Retrospective Cohort Study.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionObesity is a chronic multifactorial disease, and the Edmonton Obesity Staging System (EOSS) has been proposed as a tool to grade disease severity and estimate perioperative risk in patients undergoing metabolic and bariatric surgery (MBS). However, its association with postoperative complications in those with more advanced stages of obesity remains insufficiently explored.
objectiveTo assess the association between EOSS severity with 90-day postoperative complications after MBS.
methodsThis retrospective cohort study included patients who underwent primary laparoscopic sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) between January 2020 and December 2023. Epidemiological and clinical data, EOSS classification, and 90-day postoperative complications were collected. Complications were classified according to the Clavien-Dindo grading system. Univariate and multivariable logistic regression analyses were performed.
resultsA total of 335 patients were included, with a median age of 47 years (IQR 39-56), 81.8% were female, and the median body mass index (BMI) was 44.9 kg/m² (IQR 40.8-49.4). The prevalence of EOSS stages 3-4 was 33.4%. A significant difference was observed in the distribution of surgical techniques (p = 0.002), with an increase in SG use across more advanced EOSS. Major 90-day complication rate was 5.4% (n = 18), ranging from 1.8% in patients with EOSS 0-2 to 12.5% in those with EOSS 3-4 (p < 0.001). The reoperation rate was 1.5%, and no deaths occurred. Exploratory multivariable logistic regression models showed that higher EOSS stages were independently associated with increased odds of both overall complications (OR 1.90; 95% CI 1.30-2.80; p = 0.001) and major complications (OR 4.16; 95% CI 1.83-11.0; p = 0.0015).
conclusionAdvanced EOSS stages were associated with higher 90-day postoperative complication rates after MBS in this cohort of patients with severe obesity and substantial disease burden. While EOSS may help identify patients at increased perioperative risk, it should not be interpreted as an isolated predictor of surgical morbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.